Condition: Optic Neuritis · Sponsor: Oculis
The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).
This description comes directly from the study's public registry record.
Chief Development Officer · 617-928-5886 · info@oculis.com
Always discuss trial participation with your own doctor first.
| Kahana Oculoplastic and Orbital Surgery | Livonia, Michigan, United States | Recruiting |
| Neuro-Eye Clinical Trials | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07623668